CN Patent

CN121177273A — 包含安非他酮和半胱氨酸的药物组合物

Assigned to Antecip Bioventures II LLC · Expires 2025-12-23 · 0y expired

What this patent protects

本公开涉及包含安非他酮和半胱氨酸的药物组合物，以及包含安非他酮和半胱氨酸的药物剂型。本公开还涉及安非他酮和半胱氨酸的分子复合物。这些组合物和剂型可以提高安非他酮的稳定性。

USPTO Abstract

本公开涉及包含安非他酮和半胱氨酸的药物组合物，以及包含安非他酮和半胱氨酸的药物剂型。本公开还涉及安非他酮和半胱氨酸的分子复合物。这些组合物和剂型可以提高安非他酮的稳定性。

Drugs covered by this patent

Patent Metadata

Patent number: CN121177273A
Jurisdiction: CN
Classification: —
Expires: 2025-12-23
Drug substance claim: No
Drug product claim: No
Assignee: Antecip Bioventures II LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.